| Line Item | 2022-09-30 | Y/Y |
|---|---|---|
| Revenue | $2.49B | -16.2% |
| Cost of Revenue | $1.32B | -0.2% |
| Gross Profit | $1.17B | -29.1% |
| R&D Expense | $222.0M | -2.6% |
| SG&A Expense | $964.0M | -8.5% |
| Operating Income | -$1.88B | -1144.4% |
| Interest Expense | $224.0M | +0.9% |
| Pre-tax Income | -$2.05B | — |
| Income Tax | $47.0M | +213.3% |
| Net Income | -$2.10B | — |
| EPS (Basic) | -$24.42 | — |
| EPS (Diluted) | -$24.42 | — |
| Line Item | 2022-09-30 | Y/Y |
|---|---|---|
| Cash & Equivalents | $253.0M | -49.2% |
| Accounts Receivable | $322.0M | +4.9% |
| Inventory | $74.0M | +45.1% |
| Current Assets | $1.64B | +3.1% |
| Total Assets | $4.07B | -31.9% |
| Current Liabilities | $1.03B | -6.2% |
| Long-term Debt | $3.17B | +12.7% |
| Line Item | 2022-09-30 | Y/Y |
|---|---|---|
| Operating Cash Flow | -$312.0M | -1140.0% |
| Capital Expenditures | $108.0M | +1.9% |
| Investing Cash Flow | -$108.0M | +7.7% |
| Financing Cash Flow | $406.0M | +385.9% |
| Free Cash Flow | -$420.0M | -452.6% |
| Total Liabilities |
| $5.24B |
| -4.0% |
| Stockholders' Equity | -$1.30B | -432.1% |